Yena Lee

Research staff member in the Mood Disorders Psychopharmacology Unit, University Health Network / University of Toronto

Papers

6 publications

Trials

0 clinical trials

Key Impact

Yena Lee is a co-author on multiple influential ketamine and psychedelic psychiatry papers, including reviews and real-world studies on treatment-resistant depression and a narrative review of psilocybin and MDMA.

Background & Research

Yena Lee appears in the Mood Disorders Psychopharmacology Unit at University Health Network in Toronto and has coauthored several papers on ketamine, sleep, suicidality, and treatment-resistant depression. Her publication record also includes a broad expert opinion on ketamine/esketamine and a review of psilocybin and MDMA in mental illness, indicating work at the intersection of translational psychiatry and psychedelic medicine.

6

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

24 collaborators· click a node to visit their profile

Full network →